Bedel Financial Consulting, Inc.
Source: SEC Form 13F · as of Mar 2026Bedel Financial Consulting, Inc. holds 20 biotech & pharma companies tracked by BioSniper, totaling $331.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$331.3M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 345,976 | $318.2M |
| JNJJOHNSON & JOHNSON | 13,199 | $3.2M |
| ABBVAbbVie Inc. | 11,748 | $2.6M |
| PMPhilip Morris International Inc | 5,764 | $953K |
| PFEPFIZER INC | 33,377 | $937K |
| MRKMerck & Co., Inc. | 6,929 | $833K |
| ELVElevance Health Inc. | 2,608 | $763K |
| NVSNovartis AG | 4,682 | $715K |
| AMGNAMGEN INC | 1,606 | $565K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 7,562 | $417K |
| CAHCardinal Health Inc. | 1,683 | $356K |
| BMYBRISTOL MYERS SQUIBB CO | 5,800 | $352K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,031 | $279K |
| ABTABBOTT LABORATORIES | 2,367 | $243K |
| MCKMcKesson Corporation | 277 | $240K |
| AZNASTRAZENECA PLC | 1,200 | $237K |
| GILDGILEAD SCIENCES, INC. | 1,606 | $224K |
| RLMDRELMADA THERAPEUTICS, INC. | 10,000 | $70K |
| IRDOpus Genetics, Inc. | 15,000 | $68K |
| NOTVInotiv, Inc. | 14,945 | $4K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.